CD4 and melanoma: In a murine glioma model, VISTA‐deficient hosts exhibited enhanced control of implanted tumors that was dependent on CD4+ T cells,210 and antibody blockade of VISTA in mice bearing transplanted melanomas reduced induction of Tregs within tumors, enhanced CD8+ TIL effector function, and delayed tumor progression.72